Molecular Testing Becoming Essential in AML Treatment
Dr. DiNardo, Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, provides opinion on current treatment strategies for elderly acute myeloid leukemia (AML) patients
Published:12 December 2019
The published content on this page is not directed by any sponsors and is at the sole discretion of Caribou Publishing and the OBR editorial staff.
© Caribou Publishing. All rights reserved. Reproduction in whole or in part is prohibited.